Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Share News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
557.00    0.00 (0.00%)
Bid:
556.00
Ask:
557.00
Spread: 1.00 (0.18%)
Market Cap: £2.47b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Tate & Lyle says CP Kelco integration progressing as planned

Tue, 15th Apr 2025 14:29

(Alliance News) - Tate & Lyle PLC on Tuesday said that the integration of CP Kelco Ltd is progressing smoothly, with the two companies now operating as a single business unit since April 1.

Tate is a London-based company which supplies food and beverage products to food and industrial markets. It noted that its 2025 financial year results, as well as its fourth-quarter results, are expected to be in line with existing guidance.

In June 2024, Tate bought pectin and gums business CP Kelco for USD1.8 billion.

"We are confident in delivering the targeted run-rate cost synergies of US$50 million by the end of the 2027 financial year, and for more than 50% of these to be delivered by the end of the 2026 financial year," the firm added.

Excluding CP Kelco, Tate also expects its 2025 financial revenue to decline by 5%. Earnings before interest, taxes, depreciation, and amortization are expected to be 4% higher.

Tate has said it will release its full-year financial 2025 results on May 22.

Chief Executive Nick Hampton said: "Notwithstanding the uncertain macroeconomic environment, we are confident in the medium-term growth potential of the business we have created and are focused on delivering the benefits of the combination with CP Kelco and accelerating topline growth."

Tate shares rose 4.4% to 525.50 pence in London on Tuesday afternoon.

By Olivia Mason-Myhill, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Related News

Tate & Lyle publishes scheme document for Ingredion takeover
3 Jul 2026

Tate & Lyle publishes scheme document for Ingredion takeover

(Sharecast News) - Food ingredients manufacturer Tate & Lyle said on Friday that the scheme document for its recommended takeover by Ingredion has now...

GRAPHIC-Foreign bids help drive UK targeted M&A to new highs over $231 billion already in 2026
1 Jul 2026

GRAPHIC-Foreign bids help drive UK targeted M&A to new highs over $231 billion already in 2026

LONDON, July 1 (Reuters) - ⁠A rush of foreign bids for UK companies has ​put Britain on track to outstrip all previous records for dealmaking in 2026,...

LONDON BROKER RATINGS: Berenberg cuts Berkeley and raises Bellway
26 Jun 2026

LONDON BROKER RATINGS: Berenberg cuts Berkeley and raises Bellway

(Alliance News) - The following London-listed shares received analyst recommendations on Friday morning and on Thursday:

Tate & Lyle News

Tate & Lyle publishes scheme document for Ingredion takeover
3 Jul 2026

Tate & Lyle publishes scheme document for Ingredion takeover

(Sharecast News) - Food ingredients manufacturer Tate & Lyle said on Friday that the scheme document for its recommended takeover by Ingredion has now...

GRAPHIC-Foreign bids help drive UK targeted M&A to new highs over $231 billion already in 2026
1 Jul 2026

GRAPHIC-Foreign bids help drive UK targeted M&A to new highs over $231 billion already in 2026

LONDON, July 1 (Reuters) - ⁠A rush of foreign bids for UK companies has ​put Britain on track to outstrip all previous records for dealmaking in 2026,...

LONDON BROKER RATINGS: Berenberg cuts Berkeley and raises Bellway
26 Jun 2026

LONDON BROKER RATINGS: Berenberg cuts Berkeley and raises Bellway

(Alliance News) - The following London-listed shares received analyst recommendations on Friday morning and on Thursday:

LONDON BROKER RATINGS: Exane BNP ups Bunzl; Berenberg says 'buy' WPP
9 Jun 2026

LONDON BROKER RATINGS: Exane BNP ups Bunzl; Berenberg says 'buy' WPP

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent
9 Jun 2026

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent

(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Be...

UK's FTSE 100 recovers from lows as Israel and Iran halt strikes on each other
8 Jun 2026

UK's FTSE 100 recovers from lows as Israel and Iran halt strikes on each other

June 8 (Reuters) - UK's FTSE 100 ended flat on Monday, well off its ​session ‌lows as oil prices eased a touch after Iran and Israel said they would s...

LONDON MARKET CLOSE: Stocks mixed amid lack of Middle East progress
8 Jun 2026

LONDON MARKET CLOSE: Stocks mixed amid lack of Middle East progress

(Alliance News) - The FTSE 100 edged higher on Monday on a mixed day for stocks in London, as US markets recouped some of Friday's hefty falls and inv...